Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1362: 150-9, 2010 Nov 29.
Article in English | MEDLINE | ID: mdl-20858469

ABSTRACT

The aim of the present work was to evaluate in an early time point the effect of the cannabinoid agonist WIN 55,212-2 after hypoxic-ischemic (HI) brain injury induced by partial occlusion of the umbilical cord of premature fetal lambs. Lambs were assigned to three experimental groups: one SHAM group: non-injured animals, and two hypoxic-ischemic groups that received a dose of 0.01µg/kg WIN 55,212-2 (HI+WIN group) or not (HI+VEH) after 60min of a hypoxic-ischemic event. All animals were managed on mechanical ventilation for 3h and then sacrificed. Brains were perfusion-fixed and different regions separated for regional cerebral blood flow measurement, apoptosis quantification by TUNEL method and S-100 protein analysis by flow cytometry. The number of apoptotic cells was lower in the HI+WIN group in all regions studied. Moreover, animals treated with the cannabinoid agonist showed higher values in the percentage of S-100 positive cells in all regions, except in the cortex. In both studies we obtained similar values between SHAM group and HI+WIN group. Our results suggest that the administration of the cannabinoid agonist WIN 55,212-2 after hypoxic-ischemic brain injury in preterm lambs decreases brain injury reducing the delayed cell death and glial damage.


Subject(s)
Benzoxazines/pharmacology , Hypoxia-Ischemia, Brain/drug therapy , Morpholines/pharmacology , Naphthalenes/pharmacology , Pregnancy Complications/drug therapy , Animals , Benzoxazines/therapeutic use , Calcium Channel Blockers/pharmacology , Calcium Channel Blockers/therapeutic use , Cannabinoid Receptor Modulators/pharmacology , Cannabinoid Receptor Modulators/therapeutic use , Disease Models, Animal , Female , Fetus , Morpholines/therapeutic use , Naphthalenes/therapeutic use , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Pregnancy , Sheep, Domestic
2.
Histol Histopathol ; 24(9): 1129-38, 2009 09.
Article in English | MEDLINE | ID: mdl-19609860

ABSTRACT

UNLABELLED: The aim of this work was to evaluate the effect of magnesium sulphate (MgSO4) administration on blood-brain barrier (BBB) permeabilization after cerebral hypoxia-ischemia (HI) induced by partial occlusion of the umbilical cord of premature fetal lambs. We also characterized BBB dysfunction in terms of the levels of expression of a panel of BBB proteins; Occludin, Claudin, Zona Occludens-1, Zonula Occludens-2, VE-cadherin and beta-catenin. Lambs were assigned to: CONTROL GROUP: non-injured animals, 0 h post-partial cord occlusion (0h-PCO) group: animals subjected to 60 min HI and sacrificed just after the insult, 3h-PCO group: HI injured animals resuscitated and managed on ventilation for 3 hours and MgSO4 group: animals which received a dose of 400 mg/kg MgSO4 after the HI event and managed on ventilation for 3 hours. Brains were fixed and blocks processed for S-100 protein immunohistochemistry. Other brains were dissociated and processed for S-100 and BBB protein immunochemistry for analysis by flow cytometry. The percentage of S-100 positive cells was found to be dramatically reduced in all studied brain tissues in the 3h-PCO group with respect to the other groups. No differences were found in the percentage or mean intensity of BBB protein immunolabeled cells among the groups. In the MgSO4 group, the percentage of S-100 positive cells 3 h after the HI event was similar to the control group. These results suggest that MgSO4 treatment preserves the ischemia-induced reduction in S-100 protein without modification in the expression of endothelial tight junction molecules. We speculate that MgSO4 treatment confers neuroprotection by restoration of blood brain permeability in hypoxia-ischemia.


Subject(s)
Brain Ischemia/metabolism , Endothelium/metabolism , Magnesium Sulfate/pharmacology , Neuroprotective Agents/pharmacology , S100 Proteins/metabolism , Animals , Antigens, CD/metabolism , Blood-Brain Barrier/drug effects , Cadherins/metabolism , Case-Control Studies , Endothelium, Vascular/metabolism , Gene Expression , Hypoxia-Ischemia, Brain/metabolism , Immunohistochemistry , Membrane Proteins/metabolism , Occludin , Sheep , Time Factors , beta Catenin/metabolism
3.
Brain Res ; 1151: 161-71, 2007 Jun 02.
Article in English | MEDLINE | ID: mdl-17418109

ABSTRACT

The objective of the present study was to evaluate using premature fetal lambs the effect of cerebral hypoxia-ischemia induced by partial occlusion of the umbilical cord on the type of cell death which occurs in different brain regions and to ascertain some of the neural pathways which may underlie the associated pathologies. Lambs were sacrificed either immediately after a 1 h hypoxic-ischemic insult or 3 h later. Brains were fixed by perfusion and blocks of the different brain territories were processed for light microscopy (hematoxylin-eosin, Nissl staining), electron transmission microscopy and quantification of apoptosis by the TUNEL method. Other fixed brains were dissociated and labeled by nonyl acridine orange to determine mitochondrial integrity. Non-fixed brains were also used for membrane asymmetry studies, in which cell suspensions were analyzed by flow cytometry to quantify apoptosis. In both hypoxic-ischemic groups, necrotic-like neurons were observed mainly in the mesencephalon, pons, deep cerebellar nuclei and basal nuclei, whereas apoptotic cells were extensively found both in white and gray matter and were not limited to regions where necrotic neurons were present. The 3 h post-partial cord occlusion group, but not the 0 h group, showed a generalized alteration of cell membrane asymmetry and mitochondrial integrity as revealed by Annexin V/PI flow cytometry and nonyl acridine orange studies, respectively. Our results show that the apoptotic/necrotic patterns of cell death occurring early after hypoxic-ischemic injury are brain-region-specific and have distinct dynamics and suggest that therapeutic strategies aimed at rescuing cells from the effects of hypoxia/ischemia should be aimed at blocking the apoptotic components of brain damage.


Subject(s)
Brain/pathology , Hypoxia-Ischemia, Brain/etiology , Hypoxia-Ischemia, Brain/pathology , Neurons/pathology , Premature Birth/physiopathology , Analysis of Variance , Animals , Cell Death , DNA Degradation, Necrotic , Disease Models, Animal , Embryo, Mammalian , Female , In Situ Hybridization/methods , In Situ Nick-End Labeling/methods , Microscopy, Electron, Transmission/methods , Mitochondria/pathology , Mitochondria/ultrastructure , Neurons/ultrastructure , Pregnancy , Sheep, Domestic , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...